
Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
RDY | NYSE | USD | Real-time | |
REDYc1:NS | NSE | INR | Delayed | |
REDYc2:NS | NSE | INR | Delayed | |
REDY | NSE | INR | Real-time | |
REDY | BSE | INR | Delayed |
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company North America, Europe, India, Russia, and internationally. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segment. The Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosages with therapeutic equivalence to branded formulations, as well as engages in the biologics business. The PSAI segment manufactures and markets active pharmaceutical ingredients and intermediates, which are principal ingredients for finished pharmaceutical products. This segment also provides contract research services; and manufactures and sells active pharmaceutical ingredients and steroids with the customer requirements. The Others segment engages in developing therapies in the fields of oncology and inflammation; and research and development of differentiated formulations. The company offers its products for various therapeutic categories, including gastro-intestinal, cardiovascular, anti-diabetic, dermatology, oncology, respiratory, stomatology, urology, and nephrology, vaccines and pain management. Dr. Reddy's Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.
Name | Age | Since | Title |
---|---|---|---|
Kallam Satish Reddy | 54 | 1993 | Chairman of the Board & Member of the Management Council |
Gunupati Venkateswara Prasad | 61 | 1986 | Co-Chairman, MD & Member of Management Council |
Shikha Sanjaya Sharma | 66 | 2019 | Independent Director |
Kodumudi Pranatharthiharan Krishnan | 65 | 2022 | Independent Director |
Arun Madhavan Kumar | 71 | 2022 | Independent Director |
K. Janardhan Reddy | - | - | Member of the Scientific Advisory Board |
Leo Puri | 63 | 2018 | Lead Independent Director |
Penny Chan Wan | 58 | 2022 | Independent Director |
Alpna Hansraj Seth | 61 | 2023 | Independent Director |
Sanjiv Soshil Mehta | 64 | 2023 | Independent Director |
Claudio Albrecht | 66 | 2023 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review